Search





Search





Markets
/
Stocks
/
nasdaq-sabs
/

SAB Biotherapeutics Inc

SABS

Add to Watchlist

3.930USD

-0.070-1.75%

Close 06/22, 16:00（ET）Quotes delayed by 15 min

300.50MMarket Cap

9.19P/E TTM

SAB Biotherapeutics Inc

3.930

-0.070-1.75%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

SAB Biotherapeutics Inc's Company Valuation

Currency: USD Updated: 2026-06-22

Previous score

6.46

Change

0

The current valuation score of SAB Biotherapeutics Inc is 6.46, ranking 332 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 9.19, which is 126.36% below the recent high of 20.80 and 197.08% above the recent low of -8.92.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.

KeyAI

